1. Ray NF, Baraniuk JN, Thamer M, et al. Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis and other airway disorders. J Allergy Clin Immunol 1999;103:408-14.

2. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995;273:214-9.

3. Centers for Disease Control.Vital and Health Statistics.Current Estimates From the National Health Interview Survey, 1994. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Center for Health Statistics, 1995. DHHS publication PHS 96-1521.

4. Glicklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg 1995;113:104-9.

5. Kaliner MA, Osuguthorpe JD, Fireman P, et al. Sinusitis bench to bedside: current findings, future directions. J Allergy Clin Immunol 1997;99:S829-47.

6. Druce HM. Adjuncts to medical management of sinusitis. Otolaryngol Head Neck Surg 1990;103:880-3.

7. Zieger RS. Prospects for ancillary treatment of sinusitis in the 1990’s. J Allergy Clin Immunol 1992;90:478-93.

8. Talbot AR, Herr TM, Parsons DS. Mucociliary clearance and buffered hypertonic saline solution. Laryngoscope 1997;107:500-3.

9. Robinson M, Hemming AL, Regnis JA, et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax 1997;52:900-3.

10. Homer JJ, Dowley AC, Condon L, El-Jassar P, Sood S. The effect of hypertonicity on nasal mucociliary clearance. Clin Otolaryngol 2000;25:558-60.

11. Homer JJ, England RJ, Wilde AD, Harwood GRJ, Stafford ND. The effect of pH of douching solution on mucociliary clearance. Clin Otolaryngol 1999;24:312-5.

12. Heatley DG, McConnell KE, Kille TL, Leverson GE. Nasal irrigation for the alleviation of sinonasal symptoms. Otolaryngol Head Neck Surg 200l;125:44-8.

13. Tamooka LT, Murphy C, Davidson TM. Clinical study and literature review of nasal irrigation. Laryngoscope 2000;110:1189-93.

14. Taccariello M, Parikh A, Darby Y, Scadding G. Nasal douching as a valuable adjunct in the management of chronic rhinosinusitis. Rhinology 1999;37:29-32.

15. Bachmann G, Hommel G, Michel O. Effect of irrigation of the nose with isotonic salt solution on patients with chronic paranasal sinus disease. Eur Arch Otorhinolaryngol 2000;257:537-41.

16. Shoseyov D, Bibi H, Shai P, et al. Treatment with hypertonic saline versus normal saline wash of pediatric chronic sinusitis. J Allergy Clin Immunol 1998;101:602-5.

17. Rabone SJ, Saraswati SB. Acceptance and effects of nasal lavage in volunteer woodworkers. Occupat Med 1999;49:365-9.

18. Holmstrom M, Rosen G, Walander L. Effect of nasal lavage on nasal symptoms and physiology in wood industry workers. Rhinology 1997;35:108-12.

19. SinuCleanse Med Systems, April 22 2002. Available at: http://www.sinucleanse.com. Accessed October 7, 2002.

20. Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary test of reliability and validity. Med Care 1996;34:220-6.

21. Benninger MS, Senior BA. The development of the Rhinosinusitis Disability Index. Arch Otolyryngol Head Neck Surg 1997;123:1175-9.

22. Guyatt GH, Bombardier C, Tugwell P. Measuring disease-specific quality of life in clinical trials. CMAJ 1986;134:889-95.

23. Senior BA, Glaze C, Benninger MS. Use of the Rhinosinusitis Disability Score (RSDI) in rhinologic disease. Am J Rhinol 2001;15:15-20.

24. Deyo RA, Patrick DL. The significance of treatment effects: the clinical perspective. Med Care 1995;33:AS286-91.

25. Redelmeier DA, Guyatt GH, Goldstein RS. Assessing the minimal important difference in symptoms: a comparison of two techniques. J Clin Epidemiol 1996;49:1215-9.

26. Samsa G. How should the minimum important difference for a health-related quality-of-life instrument be estimated? Med Care 2001;39:1037-8.

27. Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407-15.

28. Bellamy N, Carr A, Dougados M, Shea B, Wells G. Towards a definition of “difference” in osteoarthritis. J Rheumatol 2001;28:427-30.

29. Powell CV, Kelly A-M. Determining the minimum clinically significant difference in visual analog pain score for children. Ann Emerg Med 2001;37:28-31.

30. Todd KH, Funk JP. The minimum clinically important difference in physician-assigned visual analog pain scores. Acad Emerg Med 1996;3:142-6.

31. Wells GA, Tugwell P, Kraag GR, et al. Minimum important difference between patients with rheumatoid arthritis: the patient’s perspective. J Rheumatol 1993;20:557-60.

32. Wendeler HM, Muller J, Dieler R, Helms J. Nasenspuling mit isotoner Emser-Salz-Losung bei chronischer rhinosinusitis. Otorhinolaryngol Nova 1997;7:254-8.